Last Word


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 2032. Category: .

Product Description

IMS Health’s Rebecca Fisher talks about what companies should do to address state and federal reporting ­requirements of transactions with physicians.

Since 2006, more than 20 states have introduced legislation requiring pharmaceutical and device manufacturers to disclose various financial transactions or exchanges of financial value to healthcare providers and affiliated healthcare organizations. Similar legislation has recently been enacted at the federal level.